Prof. Dr. Stefan Remy has officially been the new director of the LIN since 9 January 2020. He succeeds Prof. Dr. Eckart Gundelfinger as Managing Director. The scientist was previously group leader at the German Centre for Neurodegenerative Diseases (DZNE) in Bonn. The 44-year-old physician and neuroscientist investigates the complex neuronal activation patterns in the brain that control behaviour. Prof. Dr. Remy will also establish the new department "Cellular Neuroscience" at the LIN this year.

"I am very much looking forward to my time at LIN, a place where memories are researched and kept alive. Remembrances are the components of our memory and they make each of us unique," explains Prof. Dr. Stefan Remy. "Here we will work together to decipher memory, break new ground and use digitization to understand the complexity of the brain. It is our goal to advance the neuroscience location Magdeburg with open and transparent science".

On the occasion of the official inauguration of the new LIN Director, Prime Minister Dr. Reiner Haseloff thanked the outgoing Director Prof. Eckart Gundelfinger for his many years of work at the Institute. "Under your aegis, the Leibniz Institute of Neurobiology has moved, shaped and promoted the scientific landscape in Saxony-Anhalt and in has given visible and lasting impulses far beyond our federal state. We are very grateful to you for this.”

Haseloff wished Prof. Stefan Remy success and fortune. "The future of the Institute is in the hands of an excellent scientist. One can only congratulate LIN on this. I am sure: You will give the Leibniz Institute new impulses and further profile and expand the neuroscientific location Magdeburg".

In addition to Saxony-Anhalt's Prime Minister, Magdeburg’s Major Dr. Lutz Trümper, Prof. Dr. Andreas Radbruch, Director of the Leibniz Institute for Rheumatism Research Berlin, and Prof. Dr. Jens Strackeljan, Rector of the Otto von Guericke University Magdeburg, also gave welcoming speeches. Prof. Dr. Volker Haucke, Director of the Leibniz Institute for Molecular Pharmacology Berlin, paid tribute to the outgoing director.

"I am very happy that we have gained an outstanding scientist as our new director, who not only performs state-of-the-art research in the field of learning and memory, but who also has modern concepts for mentoring and governance of the institute"

Share this page: